Introduction of equity compensation stock options for directors
First written in FY2017-Q1. 17 of 23 entries say "Advanced", first in FY2017-Q2. Latest entry: FY2027-H1.
105 other companies' latest entry also says "Advanced".
- FY2027-H1AdvancedAnnual report
「Resolution date 28 May 2026 Category and number of eligible recipients Directors of the company, excluding directors who are audit and supervisory committee members and outside directors: 8 Number of stock acquisition rights: 76 (Note 1) Class, description and number of shares underlying the stock acquisition rights Common shares, 7,600 (Note 2) Exercise period 13 June 2026 to 12 June 2056」
As resolved on 28 May 2026, 76 stock acquisition rights, representing 7,600 underlying shares, were allotted to 8 eligible directors. - FY2026-H1AdvancedAnnual report
「The stock acquisition rights issued during the interim accounting period were as follows. Date of resolution 29 May 2025 Category and number of eligible recipients (people) The Company’s directors, excluding directors who are Audit and Supervisory Committee members and outside directors: 8 Number of stock acquisition rights (rights)* 66 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 6,600 (Note 2) Exercise period for the stock acquisition rights* 14 June 2025–13 June 2055」
As resolved on 29 May 2025, 66 stock acquisition rights, representing 6,600 underlying shares, were allotted to 8 eligible directors. The exercise period is from 14 June 2025 to 13 June 2055. - FY2025RestatedAnnual report
「23 May 2024 The Company’s directors: 7 Number of stock acquisition rights (rights) 59 Common shares 5,900 Exercise period for the stock acquisition rights 8 June 2024–7 June 2054」
For equity compensation stock options for officers, the 59 rights, 5,900 underlying shares and exercise period relating to the resolution of 23 May 2024 were reiterated. - FY2025-H1AdvancedAnnual report
「Resolution date 23 May 2024 Category and number of eligible recipients Directors of the company, excluding directors who are audit and supervisory committee members and outside directors: 9 Number of stock acquisition rights: 59 (Note 1) Class, description and number of shares underlying the stock acquisition rights Common shares, 5,900 (Note 2) Exercise period 8 June 2024 to 7 June 2054」
As resolved on 23 May 2024, 59 stock acquisition rights, representing 5,900 underlying shares, were allotted on 7 June 2024 to 9 eligible directors. The exercise period is from 8 June 2024 to 7 June 2054. - FY2024RestatedAnnual report
「25 May 2023 The Company’s directors: 7 Number of stock acquisition rights (rights) 72 Common shares 7,200 Exercise period for the stock acquisition rights 10 June 2023–9 June 2053」
For equity compensation stock options for officers, the 72 rights, 7,200 underlying shares and exercise period relating to the resolution of 25 May 2023 were reiterated. - FY2024-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows. Date of resolution 25 May 2023 Category and number of eligible recipients (people) The Company’s directors, excluding directors who are Audit and Supervisory Committee members and outside directors: 9 Number of stock acquisition rights (rights)* 72 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 7,200 (Note 2) Exercise period for the stock acquisition rights* 10 June 2023–9 June 2053」
As resolved on 25 May 2023, 72 stock acquisition rights, representing 7,200 underlying shares, were allotted on 9 June 2023 to 9 directors excluding directors who are Audit and Supervisory Committee members and outside directors. - FY2023-Q2AdvancedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
As resolved on 26 May 2022, 65 stock acquisition rights, representing 6,500 underlying shares, were allotted on 10 June 2022 to 7 directors. The exercise period is from 11 June 2022 to 10 June 2052. - FY2022-Q2AdvancedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
As resolved on 27 May 2021, 72 stock acquisition rights, representing 7,200 underlying shares, were allotted on 11 June 2021 to 8 directors excluding directors who are Audit and Supervisory Committee members and outside directors. The exercise period is from 12 June 2021 to 11 June 2051. - FY2021AdvancedAnnual report
「Other (exercise of stock acquisition rights) 2,900 5」
It was noted that stock acquisition rights representing 2,900 shares were exercised during the fiscal year, with total disposal proceeds of ¥5 million. - FY2021-Q2AdvancedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
As resolved on 28 May 2020, 73 stock acquisition rights, representing 7,300 underlying shares, were allotted to 9 directors. The exercise period is from 13 June 2020 to 12 June 2050. - FY2020AdvancedAnnual report
「Other (exercise of stock acquisition rights) 62,700 107」
It was noted that stock acquisition rights, including those held by directors, were exercised for 62,700 shares during the fiscal year and treasury shares were used to settle the exercise. - FY2020-Q2AdvancedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
As resolved on 23 May 2019, 96 stock acquisition rights, representing 9,600 underlying shares, were allotted to 9 directors excluding outside directors. The exercise period is from 8 June 2019 to 7 June 2049. - FY2019-Q2AdvancedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
As resolved on 24 May 2018, 79 stock acquisition rights, representing 7,900 underlying shares, were issued for the period from 9 June 2018 to 8 June 2048. - FY2018RestatedAnnual report
「The company reiterated the purpose and grant method of the stock options in the form of equity compensation. The annual report also discloses executive stock acquisition rights covering 24,000 shares for 9 directors, but does not mention a new resolution to introduce them.」
The purpose, eligible recipients and calculation method for equity compensation stock options for directors were restated. The 2017 stock acquisition rights for officers, comprising 90 rights and 9,000 underlying shares, were also noted, but no new issuance was indicated. - FY2018-Q2AdvancedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
As resolved on 25 May 2017, 90 equity compensation stock options, representing 9,000 underlying shares, were issued. The exercise period is from 10 June 2017 to 9 June 2047. - FY2017RestatedAnnual report
「In terms of management, at the annual general meeting of shareholders held in May 2016, the company approved the introduction of stock options in the form of equity compensation for its directors, excluding outside directors. The purpose is to increase the eligible directors' motivation to contribute to improving performance and corporate value over the medium to long term.」
The resolution to introduce equity compensation stock options for directors and the purpose of increasing motivation to contribute to improving performance and corporate value over the medium to long term were reiterated. - FY2017-Q3RestatedAnnual report
「In terms of management, at the annual general meeting of shareholders held in May 2016, the company approved the introduction of stock options in the form of equity compensation for its directors, excluding outside directors. The purpose is to increase the eligible directors' motivation to contribute to improving performance and corporate value over the medium to long term.」
The resolution to introduce equity compensation stock options and the purpose of increasing motivation to contribute to improving performance and corporate value over the medium to long term were reiterated. - FY2017-Q2AdvancedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
The 2016 stock acquisition rights for officers were allotted on 10 June 2016: 240 rights, representing 24,000 underlying shares, to 9 directors excluding outside directors. - FY2017-Q1First statedAnnual report
「In management matters, at the ordinary general meeting of shareholders held in May 2016, a resolution was passed to introduce equity compensation stock options for the Company’s directors, excluding outside directors. The purpose is to increase the directors’ motivation to contribute to improving performance and corporate value over the medium to long term.」
A resolution to introduce the scheme was passed at the ordinary general meeting of shareholders in May 2016, with the stated purpose of increasing motivation to contribute to improving performance and corporate value over the medium to long term.